Login
Navigate Fool.com
Will PFE beat
the market?

Pfizer (NYSE: PFE)

Community Rating: 4 Stars: Favorite

30.39 -0.10 (-0.33%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $30.69
Previous Close $30.49
Daily Range $30.32 - $30.69
52-Week Range $27.76 - $32.96
Market Cap $193.8B
P/E Ratio 18.59
Dividend (Yield) $1.04 (3.4%)
Ex-Dividend Date
Dividend Pay Date
07/30/14
09/03/14
Volume 21,100,643
Average Daily Volume 22,974,220
Current FY EPS $2.25

How do you think PFE
will perform against the market?

Top PFE Bull/Bear Pitches

 

DanCooper76 (4.84)
Submitted June 28, 2013

$10 billion buyback

0 Replies Reply Report this Post
 

taxmd (< 20)
Submitted January 25, 2011

Lipitor comes off patent in the U.S. in November, dropping revenues substantially. No suitable revenue replacement has been found.

0 Replies Reply Report this Post

News & Commentary

What Will Puma Biotechnology Inc's $700 Million Man Do Next?

A sale to Johnson & Johnson, Pfizer, Roche, or one of the other big pharmas seems like the most likely outcome for Puma Biotechnology Inc.

Why Do We Watch the Dow Jones So Closely When its Makeup Makes No Sense?

Weighting components by price can lead to all sorts of problems when you're not watching the right stocks.

Closing Update: Blue Chips Decline But Broader Indices Extend Gains On Mostly Positive Earnings Resu

Closing Update: Blue Chips Decline But Broader Indices Extend Gains On Mostly Positive Earnings Results

Puma Biotechnology Stock Shoves It in Short Sellers' Faces

Shares of Puma Biotechnology are up almost 300% after the company posted strong top-line results for its flagship cancer drug neratinib. Here's what investors need to know moving forward.

Sector Update: Health Care Stocks Mostly Higher Near Bell; Vascular Solutions Up Almost 10% After Q2

Sector Update: Health Care Stocks Mostly Higher Near Bell; Vascular Solutions Up Almost 10% After Q2 EPS Beat, Q3 Outlook

Why Puma Biotechnology Inc Stock More Than Tripled Today

Shares of the clinical-stage biotech launch into the stratosphere after a phase 3 trial success

Roche Earnings Preview: Continued Adoption For Key Cancer Drugs Will Drive Growth

Puma Biotechnology Inc's Overnight Triple is Just the Beginning

Pfizer gives Puma Biotechnology a gift, while Puma might be able to steal sales from Roche.

The 4 Stocks That Weighed Down the Market

Pfizer's Stock Falls Ill as the Dow Tumbles

AbbVie's stock falls after its market-shaking deal to acquire Shire on Friday.

See More PFE News...

Sector

Healthcare

Industry

Drugs

Pfizer (PFE) Description

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra. Website: http://www.pfizer.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks